Metabolic phenotype and gender may predict treatment outcomes of atezolizumab in extensive-stage small cell lung cancer.

365 U/L in males, P=0.07) in female patients, although these differences did not reach statistical significance at the P<0.05 threshold.

also in 111,027 other papers

Normal-range uric acid level (4.0–5.9 mg/dL) showed a trend towards better survival but did not reach statistical significance in this model (P=0.11).

also in 53,322 other papers

This was not found in the pre-atezolizumab group, where there was a slight trend towards better survival for male patients.

also in 4,078 other papers